NY A 1522
in committeeRequires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment
New York · 2025-2026 Regular Session · lower
Quick answers
Did NY A 1522 pass?
Not yet. NY A 1522 is in committee as of 2026-01-07 and has not come to a final vote. Latest recorded action (2026-01-07): REFERRED TO ALCOHOLISM AND DRUG ABUSE
What is NY A 1522 about?
Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction.
Who sponsors NY A 1522?
David Weprin is the primary sponsor of NY A 1522, joined by 2 cosponsors.
Description
Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction.
- Introduced
- —
- Latest action
- 2026-01-07 — REFERRED TO ALCOHOLISM AND DRUG ABUSE
- Bill type
- bill
- Last updated
- —
Sponsors
- David Weprinprimary
- Maritza Davilacosponsor
- Keith Browncosponsor
Committees
Not provided by source.
Action timeline
2025-01-10
REFERRED TO ALCOHOLISM AND DRUG ABUSE
referral-committee
2026-01-07
REFERRED TO ALCOHOLISM AND DRUG ABUSE
referral-committee
Versions
- A1522Compare
Documents
Votes
Not provided by source.
Related bills
- Prior session: A 6210not in this corpus
- Companion bill: S 1817
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 1522. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.